tiprankstipranks
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
US Market

Eledon Pharmaceuticals (ELDN) Financial Statements

Compare
821 Followers

Eledon Pharmaceuticals Financial Overview

Eledon Pharmaceuticals's market cap is currently $189.23M. The company's EPS TTM is $-2.911; its P/E ratio is ―; Eledon Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 120.00K
Gross Profit$ 0.00$ -374.00K$ -373.00K$ -195.00K$ -63.00K
Operating Income$ 0.00$ -43.00M$ 8.49M$ -36.87M$ -18.46M
EBITDA$ 0.00$ 0.00$ -87.59M$ -36.66M$ -23.03M
Net Income$ -35.32M$ -40.33M$ -87.50M$ -34.51M$ -22.81M
Balance Sheet
Cash & Short-Term Investments$ 140.18M$ 51.10M$ 56.41M$ 84.83M$ 114.19M
Total Assets$ 177.41M$ 89.07M$ 92.79M$ 170.55M$ 197.19M
Total Debt$ 954.00K$ 383.00K$ 746.00K$ 769.00K$ 144.00K
Net Debt$ -19.59M$ -4.23M$ -55.66M$ -84.06M$ -114.05M
Total Liabilities$ 59.27M$ 81.86M$ 8.61M$ 6.55M$ 6.59M
Stockholders' Equity$ 118.14M$ 7.21M$ 84.18M$ 164.00M$ 190.60M
Cash Flow
Free Cash Flow$ -47.27M$ -39.53M$ -28.42M$ -28.91M$ -15.21M
Operating Cash Flow$ -47.27M$ -39.53M$ -28.42M$ -28.91M$ -15.21M
Investing Cash Flow$ -70.31M$ -45.29M$ 0.00$ 0.00$ 11.04M
Financing Cash Flow$ 133.52M$ 33.02M$ 0.00$ -449.00K$ 109.58M
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History

Eledon Pharmaceuticals Debt to Assets

Eledon Pharmaceuticals Cash Flow

Eledon Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis